Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT06584630 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-09-19
Summary
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.
Conditions
Sponsors & Collaborators
-
Aristotle University Of Thessaloniki
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 ·Status: COMPLETED
-
Analysis of miRNA Expression in Endometrial Cancer
NCT04845425 ·Status: UNKNOWN
-
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
NCT05888636 ·Status: RECRUITING
-
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer
NCT05542940 ·Status: COMPLETED
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956 ·Status: RECRUITING
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.
NCT06279832 ·Status: RECRUITING ·Phase: NA
-
The Role of CircDENND4C in Epithelial Ovarian Cancer
NCT06617585 ·Status: NOT_YET_RECRUITING
-
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
NCT04604613 ·Status: ACTIVE_NOT_RECRUITING
-
A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
NCT06007300 ·Status: NOT_YET_RECRUITING
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
NCT06250010 ·Status: RECRUITING
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783 ·Status: COMPLETED
-
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
NCT06083779 ·Status: UNKNOWN
-
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique
NCT03766672 ·Status: COMPLETED
-
Single-cell RNAseq Breast Cancer
NCT05807516 ·Status: UNKNOWN
-
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00758056 ·Status: UNKNOWN
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
miRNAs in High Grade Serous Ovarian Cancer
NCT05146505 ·Status: UNKNOWN
-
Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
NCT06877910 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Markers in Treatment in Endometrial Cancer
NCT00598845 ·Status: UNKNOWN